Mortality After Stereotactic Radiosurgery for Brain Metastases and Implications for Optimal Utilization-Reference-Cited by-同舟云学术

Mortality After Stereotactic Radiosurgery for Brain Metastases and Implications for Optimal Utilization

Published:2018-11 Issue:11 Volume:41 Page:1142-1147
ISSN:0277-3732
Container-title:American Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Rydzewski Nicholas R.,Khan Atif J.,Strauss Jonathan B.,Chmura Steven J.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference30 articles.

1. Management of brain metastases;Wen;Oncology (Williston Park),1999

2. Current management of brain metastases, with a focus on systemic options;Langer;J Clin Oncol,2005

3. Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial;Mulvenna;Lancet,2016

4. NCCTG N0574 (Alliance): a phase III randomized trial of whole brain radiation therapy (WBRT) in addition to radiosurgery (SRS) in patients with 1 to 3 brain metastases;Brown;J Clin Oncol,2015

5. Effect of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases: a randomized clinical trial;Brown;JAMA,2016

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline;Journal of Clinical Oncology;2022-02-10

2. Interrupted Time-Series Analysis of Stereotactic Radiosurgery for Brain Metastases Before and After the Affordable Care Act;Cureus;2022-01-17

3. Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline;Neuro-Oncology;2021-12-21

4. NTCP modeling and dose–volume correlations for acute xerostomia and dry eye after whole brain radiation;Radiation Oncology;2021-03-21

5. Genesis of Quality Measurements to Improve the Care Delivered to Patients With Brain Metastases;JCO Oncology Practice;2021-03